Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Hierarchical dual-conductive networks enable high-cell-density spheroid bioprinting for volumetric muscle loss repair.

Wang P., Gao T., Yang S., Zheng H., Ye H., Huang P.

Animal Study on Scar, published in Acta Biomater (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Acta Biomater (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
42373035
DOI
10.1016/j.actbio.2026.06.058

Abstract (original English)

Volumetric muscle loss (VML) remains a significant clinical challenge, as the intrinsic regenerative capacity of skeletal muscle is insufficient for restoring large tissue defects, often leading to extensive fibrotic scarring. While 3D bioprinting enables precise control over tissue architecture, challenges remain in high-cell-density printing and in maintaining cell viability during extrusion and photocrosslinking. Herein, we report a dual-conductive, cell spheroid-laden, bioprinted hydrogel construct for in situ VML repair. Specifically, myogenically differentiated adipose-derived stem cells (M-ADSCs) were assembled with carbon nanotube-loaded short fibers (F C ) into cell spheroids (F C -CS). These spheroids were then encapsulated within a hydrogel matrix containing additional F C , yielding the final F C -CS@Gel-F C . This spheroid-based printing strategy effectively shields M-ADSCs from nozzle-induced shear stress during high-cell-density bioprinting, while the integrated F C establishes a dual-conductive network. This network functions as an internal micro-scaffold within spheroids while forming conductive bridges between them in hydrogels, thereby enhancing electrical signal transmission, promoting cytoskeletal proteins expression, and facilitating myotube fusion. In vivo evaluation in a VML rat model demonstrates that F C -CS@Gel-F C significantly suppresses fibrotic sc

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsBioprintingSpheroids, CellularMuscle, SkeletalHydrogelsRatsStem CellsTissue ScaffoldsPrinting, Three-DimensionalRats, Sprague-Dawley

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research